Dashboard
High Management Efficiency with a high ROE of 17.37%
Company has a low Debt to Equity ratio (avg) at 0 times
Flat results in Sep 25
With ROE of 16.4, it has a Very Expensive valuation with a 8.4 Price to Book Value
High Institutional Holdings at 37.11%
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Industrial Products
INR 24,439 Cr (Small Cap)
50.00
40
1.07%
-0.12
16.43%
8.23
Total Returns (Price + Dividend) 
Latest dividend: 36 per share ex-dividend date: Jul-25-2025
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
29-Jan-2026 | Source : BSEPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you about schedule of conference call as per details given below: Day and Date: Monday 9 February 2026 Time: 4:30 PM (IST) Arranged by: B&K Securities Type of Meeting: Conference Call/Group Meet Detailed invite is attached herewith. The above schedule is subject to change if any due to exigencies.
Board Meeting Intimation for Board Meeting Date
13-Jan-2026 | Source : BSETimken India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that a Meeting of the Board of Directors of the Company will be held on Wednesday 4 February 2026 inter-alia to consider and approve Unaudited Consolidated Financial Results of the Company for the quarter and nine months ended 31 December 2025. Kindly request you to take this on record.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Jan-2026 | Source : BSEPursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed certificate received from our Registrar and Share Transfer Agent (CB Management Services Private Limited) confirming that the share certificates received for dematerialization have been mutilated and cancelled after due verification and the name of the respective depository has been substituted in the records as the registered owner within stipulated timelines for the quarter ended 31 December 2025. Kindly request you to take this on record.
Corporate Actions 
No Upcoming Board Meetings
Timken India Ltd has declared 360% dividend, ex-date: 25 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 26 Schemes (25.36%)
Held by 132 FIIs (6.94%)
Timken Singapore Pte Ltd (51.05%)
Hdfc Mutual Fund - Hdfc Mid-cap Fund (7.82%)
8.79%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -4.43% vs -13.94% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -14.15% vs -44.22% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 2.94% vs 9.79% in Sep 2024
Growth in half year ended Sep 2025 is 3.99% vs 1.68% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 9.75% vs 0.38% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 3.93% vs -12.41% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 8.19% vs 3.67% in Mar 2024
YoY Growth in year ended Mar 2025 is 14.09% vs 0.36% in Mar 2024